Hybrid Heart in Diabetes conference offers ‘new twist’ on latest cardiometabolic research
Click Here to Manage Email Alerts
Experts across the cardiorenal metabolic specialties will again convene to present innovative research on the relationship between type 2 diabetes, CVD and renal disease, including controversial debates and panel discussions.
The sixth annual Heart in Diabetes CME Conference, described as where the heart, kidney and diabetes meet in clinical practice, will take place Friday through Sunday at the Loews Philadelphia Hotel. Once again, the 3-day conference will be hybrid, combining live in-person and live-online sessions, followed by 90 days of on-demand access.
The conference is structured to help clinicians improve care for patients with diabetes, CVD, chronic kidney disease, HF and related conditions, distilling the latest trial data and their relevance across the specialties. Until recently, the disorders were treated as separate conditions; recently published practice guidelines, developed by the Diabetes, CardioRenal Metabolic Diseases Task Force, now cover 18 interrelated cardiometabolic disorders and are for use by primary care physicians and specialists, according to conference co-chair Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE. A special session highlighting the guideline recommendations, led by Handelsman and task force members, will be held Saturday.
“The faculty here, each one is top in their field — society presidents, journal editors, leaders in HF, lipid management, management of hyperglycemia,” Handelsman, also medical director and principal investigator of the Metabolic Institute of America in Tarzana, California and an Endocrine Today Editorial Board Member, told Healio. “When you go to a meeting, maybe you can see a few experts, but not this many people across specialties in the same place at the same time. This is incredibly different. Attendees can also meet the faculty during breaks and the posters reception. This is a rare opportunity to interact with the best of the best. During this new era of so-called cardiorenal metabolic risk, this meeting exemplifies how to bring these experts and information together.”
Attendees can earn up to 26.25 CME and ABIM credit points during the conference, with all sessions available for 90 days after the program concludes, Handelsman said.
Conference highlights include the following:
On Friday at 8:15 a.m., Heart in Diabetes with Circulation will feature presentations on race differences in the effect of SGLT2 inhibition on HF with Alanna A. Morris, MD, outcomes of participants with diabetes in the ISCHEMIA trials with Jonathan D. Newman, MD, MPH, trends and inequities in diabetes outcomes with Sadiya Khan, MD, and highlights from the American Heart Association scientific statement on managing CV risk factors in adults with type 2 diabetes with Joshua J. Joseph, MD, MPH, FAHA. “Our chair, Darren McGuire, MD, chose the most important papers that relate to this relationship of diabetes and the heart,” Handelsman said.
A session on digital health and technology will include presentations from Richard Bergenstal, MD, on the role of continuous glucose monitoring in diabetes and beyond, and from Seth S. Martin, MD, on digital health technology and mobile devices in diabetes and heart disease. “We will present an interesting and different look at digital technology that is not just from the endocrinologist’s point of view, but also a cardiologist’s point of view,” Handelsman said. “This is a new twist on a session we previously had.”
Several experts will also debate the role of aspirin and antiplatelet therapy on Friday at 2:20 p.m., with Laurence S. Sperling, MD, Peter J. Grant, MD, and Robert J. Chilton, DO, discussing the latest research. “People really do not know what is best,” Handelsman said. “Every day, it seems there is a different recommendation on whether or not to use aspirin.”
Which test is better? On Friday at 4:05 p.m. James Udelson, MD, and Norman E. Lepor, MD, will debate the utility of the nuclear stress test vs. the CT angiography test, and Matthew J. Budoff, MD, will highlight the ABCs of calcium scoring and the test controversies.
Lee Goldberg, MD, Michael Snyder, MD, and William T. Cefalu, MD, will lead discussions on COVID-19, diabetes and the heart on Saturday at 8:10 a.m.
Ralph DeFronzo, MD, will receive the Luminary in Cardiometabolic Medicine award on Sunday at 9:30 a.m., and will speak on the urgent need to treat “pre-prediabetes.”
Every day concludes with a 1-hour panel discussion with featured faculty discussing and responding to questions. The meeting will also feature abstract presentations from scientists and researchers around the world, as well as several non-CME, industry-supported presentations. Abstracts will be published in the American Heart Journal.
The Cardiology Today, Endocrine Today and Healio staffs will provide live coverage from the Heart in Diabetes CME Conference, including reports on the sessions, debates, video interviews and much more. For more information on the Heart in Diabetes conference and registration, visit www.heartindiabetes.com.
Collapse
Healio Interviews
Click Here to Manage Email Alerts